New cancer clinical trial: A Phase II Study of RC48-ADC in Subjects With HER2 Positive Metastatic or Unresectable Urothelial Cancer

Published on: April 24, 2018 at 12:00PM
Conditions:   Urothelial Carcinoma;   Advanced Cancer
Intervention:   Drug: RC48-ADC
Sponsor:   RemeGen
Recruiting
https://ift.tt/2vG3Zeh